These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 18682151

  • 1. [Response of thyroglobulin, anti-thyroglobulin antibodies, TSH, FT4 and total T3 after rhTSH stimulation in differentiated thyroid carcinoma].
    Moreno Ortega E, Vallejo Casas JA, Mena Bares LM, del Real Núñez R, Maza Muret FR, Hidalgo Ramos FJ, Latre Romero JM.
    Rev Esp Med Nucl; 2008; 27(4):253-8. PubMed ID: 18682151
    [Abstract] [Full Text] [Related]

  • 2. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma.
    Mazziotti G, Sorvillo F, Piscopo M, Cioffi M, Pilla P, Biondi B, Iorio S, Giustina A, Amato G, Carella C.
    J Bone Miner Res; 2005 Mar; 20(3):480-6. PubMed ID: 15746993
    [Abstract] [Full Text] [Related]

  • 3. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
    Vincze B, Sinkovics I, Keresztes S, Gergye M, Boér A, Remenár E, Péter I, Szentirmay Z, Kremmer T, Kásler M.
    Magy Onkol; 2004 Mar; 48(1):27-34. PubMed ID: 15105893
    [Abstract] [Full Text] [Related]

  • 4. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
    Giovanella L, Ceriani L, Suriano S, Ghelfo A, Maffioli M.
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
    [Abstract] [Full Text] [Related]

  • 5. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma.
    Heemstra KA, Liu YY, Stokkel M, Kievit J, Corssmit E, Pereira AM, Romijn JA, Smit JW.
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):58-64. PubMed ID: 17201802
    [Abstract] [Full Text] [Related]

  • 6. Do thyroid cancer patients with basal undetectable Tg measured by current immunoassays require rhTSH testing?
    Díaz-Soto G, Puig-Domingo M, Martínez-Pino I, Martínez de Osaba MJ, Mora M, Rivera-Fillat F, Halperin I.
    Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):348-52. PubMed ID: 21264807
    [Abstract] [Full Text] [Related]

  • 7. Follow-up of differentiated thyroid carcinoma.
    Pagano L, Klain M, Pulcrano M, Angellotti G, Pasano F, Salvatore M, Lombardi G, Biondi B.
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [Abstract] [Full Text] [Related]

  • 8. [Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma].
    Zöphel K, Wunderlich G, Liepach U, Koch R, Bredow J, Franke WG.
    Nuklearmedizin; 2001 Oct; 40(5):155-63. PubMed ID: 11727628
    [Abstract] [Full Text] [Related]

  • 9. Thyroglobulin measurement. Techniques, clinical benefits, and pitfalls.
    Spencer CA, Wang CC.
    Endocrinol Metab Clin North Am; 1995 Dec; 24(4):841-63. PubMed ID: 8608781
    [Abstract] [Full Text] [Related]

  • 10. Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients.
    Pötzi C, Moameni A, Karanikas G, Preitfellner J, Becherer A, Pirich C, Dudczak R.
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):519-23. PubMed ID: 16984246
    [Abstract] [Full Text] [Related]

  • 11. A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later.
    Kloos RT, Mazzaferri EL.
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5047-57. PubMed ID: 15972576
    [Abstract] [Full Text] [Related]

  • 12. Real time RT-PCR analysis of thyroglobulin mRNA in peripheral blood in patients with congenital athyreosis and with differentiated thyroid carcinoma after stimulation with recombinant human thyrotropin.
    Kaufmann S, Schmutzler C, Schomburg L, Körber C, Luster M, Rendl J, Reiners C, Köhrle J.
    Endocr Regul; 2004 Jun; 38(2):41-9. PubMed ID: 15497927
    [Abstract] [Full Text] [Related]

  • 13. Age influences TSH serum levels after withdrawal of l-thyroxine or rhTSH stimulation in patients affected by differentiated thyroid cancer.
    Montesano T, Durante C, Attard M, Crocetti U, Meringolo D, Bruno R, Tumino S, Rubello D, Al-Nahhas A, Colandrea M, Maranghi M, Travascio L, Ronga G, Torlontano M.
    Biomed Pharmacother; 2007 Sep; 61(8):468-71. PubMed ID: 17553654
    [Abstract] [Full Text] [Related]

  • 14. Evidence of central hypothyroidism in children on continuous ambulatory peritoneal dialysis.
    Düsünsel R, Poyrazoglu HM, Gündüz Z, Kurtoglu S, Kiris A, Günes T.
    Adv Perit Dial; 1999 Sep; 15():262-8. PubMed ID: 10682115
    [Abstract] [Full Text] [Related]

  • 15. Maternal thyroid function at 11-13 weeks of gestation.
    Ashoor G, Kametas NA, Akolekar R, Guisado J, Nicolaides KH.
    Fetal Diagn Ther; 2010 Sep; 27(3):156-63. PubMed ID: 20413976
    [Abstract] [Full Text] [Related]

  • 16. Value of diagnostic radioiodine scintigraphy and thyroglobulin measurements after rhTSH injection.
    Verburg FA, de Keizer B, de Klerk JM, Lentjes EG, Lips CJ, van Isselt JW.
    Nuklearmedizin; 2009 Sep; 48(1):26-9. PubMed ID: 19212608
    [Abstract] [Full Text] [Related]

  • 17. Monitoring differentiated thyroid cancer patients with negative serum thyroglobulin. Diagnostic implication of TSH-stimulated antithyroglobulin antibody.
    Nam HY, Paeng JC, Chung JK, Kang KW, Cheon GJ, Kim Y, Park DJ, Park YJ, Min HS, Lee DS.
    Nuklearmedizin; 2014 Sep; 53(2):32-8. PubMed ID: 24276613
    [Abstract] [Full Text] [Related]

  • 18. [The correlation between endogenous TgAb and experimental Tg values in patients with differentiated thyroid carcinomas].
    Tang GS, Xu J, Yu Y, Pan MZ, Wang JR, Yuan LP, Jiang T, Huang F, Jing CL.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 42(6):856-60. PubMed ID: 22332559
    [Abstract] [Full Text] [Related]

  • 19. The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels.
    Pellegriti G, Scollo C, Regalbuto C, Attard M, Marozzi P, Vermiglio F, Violi MA, Cianci M, Vigneri R, Pezzino V, Squatrito S.
    Clin Endocrinol (Oxf); 2003 May; 58(5):556-61. PubMed ID: 12699436
    [Abstract] [Full Text] [Related]

  • 20. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
    Romão R, Rubio IG, Tomimori EK, Camargo RY, Knobel M, Medeiros-Neto G.
    Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.